Clinical Trials Directory

Trials / Completed

CompletedNCT01435811

Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Children's Hospital Medical Center, Cincinnati · Academic / Other
Sex
All
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine a suitable dose of the human norovirus GII.4 challenge pool(CIN-1;031693) that induces illness in approximately 50% of susceptible subjects that would be useful for evaluation of vaccines and antivirals.

Conditions

Interventions

TypeNameDescription
BIOLOGICALNorovirus challenge pool (GII.4, CIN-1)Norovirus challenge pool (GII.4, CIN-1)

Timeline

Start date
2011-08-01
Primary completion
2012-04-01
Completion
2012-11-01
First posted
2011-09-19
Last updated
2014-05-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01435811. Inclusion in this directory is not an endorsement.

Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1) (NCT01435811) · Clinical Trials Directory